Long-term lithium therapy: side effects and interactions

E Ferensztajn-Rochowiak, JK Rybakowski - Pharmaceuticals, 2023 - mdpi.com
Lithium remains the drug of first choice for prophylactic treatment of bipolar disorder,
preventing the recurrences of manic and depressive episodes. The longitudinal experiences …

Mechanisms of neuroplasticity and brain degeneration: strategies for protection during the aging process

M Toricelli, AAR Pereira, GS Abrao… - Neural regeneration …, 2021 - journals.lww.com
Aging is a dynamic and progressive process that begins at conception and continues until
death. This process leads to a decrease in homeostasis and morphological, biochemical …

Is lithium neuroprotective? An updated mechanistic illustrated review

F Ghanaatfar, A Ghanaatfar, P Isapour… - Fundamental & …, 2023 - Wiley Online Library
Neurodegeneration is a pathological process characterized by progressive neuronal
impairment, dysfunction, and loss due to mitochondrial dysfunction, oxidative stress …

New advances in the pharmacology and toxicology of lithium: a neurobiologically oriented overview

A Bortolozzi, G Fico, M Berk, M Solmi, M Fornaro… - Pharmacological …, 2024 - Elsevier
Over the last six decades, lithium has been considered the gold standard treatment for the
long-term management of bipolar disorder due to its efficacy in preventing both manic and …

Lithium promotes recovery after spinal cord injury

YJ Zhao, H Qiao, DF Liu, J Li, JX Li… - Neural regeneration …, 2022 - journals.lww.com
Lithium is associated with oxidative stress and apoptosis, but the mechanism by which
lithium protects against spinal cord injury remains poorly understood. In this study, we found …

Medicinal inorganic chemistry: An updated review on the status of metallodrugs and prominent metallodrug candidates

VM Miranda - Reviews in Inorganic Chemistry, 2022 - degruyter.com
Metallodrugs correspond to a small portion of all available drugs in the market and, yet,
some of them are among the most used and important drugs in modern medicine. However …

Psychopharmaka

MJ Lohse, A Lorenzen… - … -Report 2002: Aktuelle …, 2003 - Springer
Zusammenfassung Die Verordnungsstruktur der Psychopharmaka hat sich in den letzten 10
Jahren auffällig verändert. Die Verordnungen der früher führenden Tranquillantien haben …

Challenging the negative perception of lithium and optimizing its long-term administration

JK Rybakowski - Frontiers in molecular neuroscience, 2018 - frontiersin.org
The use of lithium for the prevention of recurrences in mood disorders has a 55-year history.
Nowadays, lithium is universally accepted as the first-choice mood-stabilizer (MS) for …

The neuroprotective mechanism of lithium after ischaemic stroke

B Chen, M Zhang, M Ji, D Zhang, B Chen… - Communications …, 2022 - nature.com
Stroke causes degeneration and death of neurones leading to the loss of motor function and
frequent occurrence of cognitive impairment and depression. Lithium (Li+), the archetypal …

Ultra-long-term lithium therapy: all-important matters and a case of successful 50-year lithium treatment

E Ferensztajn-Rochowiak… - Brazilian Journal of …, 2020 - SciELO Brasil
This paper discusses essential issues related to long-term lithium therapy and presents a
case of successful 50-year lithium treatment. Lithium is currently regarded as the drug of …